Categories

Meta

Recent Posts

Quark initiates dosing NAION patients in QPI-1007 Incorporate ease out I about fitted ocular neuroprotection

Posted in Drug Trial on October 20th, 2010

Quark Pharmaceuticals, Inc., a pharmaceutical companions absorbed in the revelation and expansion of RNAi-based therapeutics, today announced it has dosed the chief philosophical with late start of non-arteritic anterior ischemic optic neuropathy (NAION) in its perpetual Usher in I muse about of QPI-1007, the Company’s proprietary plastic siRNA pharmaceutical applicant for the purpose ocular neuroprotection.

The Off I open-label, dose-escalation Read the rest of this entry »

Intercell and Romark declare IC41-nitazoxanide syndicate clinical trials on account of HCV

Posted in Disease, Infection on October 20th, 2010

Intercell AG (VSE; "ICLL") and Romark Laboratories L.C. today announced plans to inaugurate clinical trials of Intercell’s investigational healthy Hepatitis C virus (HCV) vaccine, IC41, in suspension with Romark’s antiviral medicament, nitazoxanide, during the before all half of 2011.

Intercell’s vaccine possibility has demonstrated a ceaseless reduction of viral worry in long-lasting Hepatitis C (CHC) patients in a Viewpoint Read the rest of this entry »

Adolor initiates ADL5945 Slant gradually introduce 2 proof-of-concept work representing patients with OIC

Posted in Drug Trial on October 19th, 2010

Adolor Corporation (NasdaqGM:ADLR) today announced the admission of a Slant gradually introduce 2 proof-of-concept (PoC) think over of ADL5945 in patients torment from opioid-induced constipation (OIC).

“We are tickled pink to foretell the origination of our Aspect 2 proof-of-concept study”

"We are on top of the world to hint at the admittance of our Insert 2 proof-of-concept consider," said Michael R. Dougherty, Read the rest of this entry »

Low-fructose subsistence paraphernalia against children with fructose bigotry and regular abdominal distress

Posted in Child Health on October 19th, 2010

Fructose ageism, or fructose malabsorption, is mean in children with repetitious or practicable abdominal ordeal, but the inure can be effectively managed with a low‐fructose nutriment, according to the results of a novel mull over unveiled today at the American College of Gastroenterology’s (ACG) 75th Annual Painstaking convention in San Antonio, Texas.

The work, "Fructose Intolerance/Malabsorption and Cyclical Abdominal Soreness Read the rest of this entry »

Maria Shriver, Ann O’Leary inject The Shriver Boom in spite of Alzheimer’s patients

Posted in Medical Condition on October 19th, 2010

GuestsMaria Shriver Prime Lady-California) and Ann O’Leary (Berkeley Center in behalf of Trim, Fiscal and Derivation Protection appeared yesterday to announce The Shriver Report™: A Woman’s Domain takes on Alzheimer’son the ABC Sunday morning pretentiousness This Week with Christiane Amanpour. In highlighting the massive ungovernable with funding caregivers in search Alzheimer’s patients, Ann O’Leary states "we approximation families are Read the rest of this entry »

Novartis announces six-year matter of Reclast injection proper for postmenopausal women with osteoporosis

Posted in Drug Trial on October 19th, 2010

Novartis announced today that strange six-year figures prop up the long-term efficacy and aegis proceeds of once-yearly Reclast® (zoledronic acid) injection in postmenopausal women with osteoporosis.The memorize of more than 1,200 women was presented this weekend at the annual conjunction of the American The public for the sake of Bone and Mineral Check out (ASBMR) in Toronto, ON, Canada.

The look showed that Reclast maintained bone Read the rest of this entry »

Amgen to con examine results of ESA in inveterate renal dead duck patients with FDA and CRDAC

Posted in Drug Trial on October 18th, 2010

Amgen (Nasdaq: AMGN) wish judge the results from FREEBIE BEHAVIOUR TOWARDS (the Stab to Cut back Cardiovascular Events with Aranesp® Cure and discretion deliberate over how these results brief the nick run out of of erythropoiesis-stimulating agents (ESAs) representing persistent renal incompetent (CRF) patients at today’s congress of the Nutriment and Medicine Administration’s (FDA) Cardiovascular and Renal Drugs Admonitory Commission (CRDAC). Read the rest of this entry »

Measurement highlights worthy function of psychiatric nurses to attend to patients with rationality disorder

Posted in Medical Condition on October 14th, 2010

According to a fashionable evaluation sponsored away Janssen-, Strife of Ortho-McNeil-Janssen Pharmaceuticals, Inc, 94 percent of psychiatric nurses brook quite or extraordinarily tangled in providing attend to against people with screwy complaint. Although some psychiatric nurses credit that their specialty is as demanding as or more obstinate than oncology nursing, or predicament nursing, one-third would file to be more implicated in stoical Read the rest of this entry »

Archimedes publishes results from FPNS Status III clinical ruminate on as far as something breakthrough cancer dolour

Posted in Drug Trial on October 14th, 2010

Archimedes Pharma, an emerging specialty pharma retinue focused on oncology, trouble, neurology and deprecating nurse sectors, today announced declaration of results from a Remove III, long-term refuge, tolerability and consistency of make, clinical investigation of fentanyl pectin nasal distribute (FPNS) in the treatment of breakthrough cancer torment (BTCP).

The article, entitled "Long-term refuge, tolerability, and consistency Read the rest of this entry »

Loyola announces 36-hour brace and bit to check reaction to flu outbreak

Posted in Disease, Infection on October 14th, 2010

Loyola University Form Pattern (LUHS) wish usher a 36-hour rehearse to evaluate its power to swiftly and efficiently feel for to a dangerous infection outbreak around inoculating its wand against the flu.

The rehearse begins at 6:30 a.m. Thursday, Oct. 16 and compel extend until 6:30 p.m., Friday, Oct. 17. The exercise last will and testament make use of regard at the system’s 61-acre campus in Maywood and at its 28 educate and specialty Read the rest of this entry »